ActX, a Seattle startup that is developing technologies to make patient genomic data more useful in medical practice, has raised $1.9 million from members of the Alliance of Angels.
ActX founder and CEO Andrew Ury said the deal was oversubscribed in the first six weeks, noting the “speed and efficiency” of the investors.
Part of that might be tied to Ury himself. An established entrepreneur, Ury previously founded Practice Partner, a pioneer in electronic health records that was acquired by McKesson in 2007. At the time, Practice Partner had more than 1,500 medical practices, representing approximately 6,000 physicians, using the service. Ury, who did his Residency at the University of Washington and practiced medicine on Vashon Island, left an executive role at McKesson in 2009 to found Aucolla.
“We were blown away by Andrew, the caliber of the team he’s assembled, and his vision for building the next great biotech company in Seattle.” said Yi-Jian Ngo, Managing Director at Alliance of Angels in a press release.
